Even without IBD, DXPE will march up to the 40 - 50 level in six months, based on current 06' eps projections of 1.94. JM Dutton is so conservative. The analyst even says it in his research note.
"We are assigning a 12-month target price for these shares utilizing a price/earnings multiple of 20 times 2006 estimated EPS of $1.00, or $20.00. As we gain a clearer picture of 2006, WE BELIEVE THE OPPORTUNITY EXISTS FOR FURTHER SIGNIFICANT UPWARD PRICE TARGET REVISIONS. Accordingly, we are maintaining our Buy rating despite the recent strength in these shares". =======================================================================
A buy recommendation is a joke based on the above statement (IN CAPS).
The analyst just raised the forward pe to 20, from 15...
...and has raised 2006 eps from .70 three months ago, to .85 last month, now to 1.00.
Gee, I wonder what he will raised it to next. Who cares!
He needs to grow some balls, upgrade DXPE to a strong buy with a $50 twelve month price target, and 2006 eps estimates of $1.94.
If we retail investors can figure it out, so can he.